Literature DB >> 7403667

Metabolism of methotrexate in man after high and conventional doses.

K K Chan, M S Nayar, J L Cohen, R T Chlebowski, H Liebman, D Stolinsky, M S Mitchell, D Farquhar.   

Abstract

Methotrexate has been found to be extensively metabolized to 7-hydroxymethotrexate in patients receiving conventional doses (less than 10 mg/kg) and high doses (greater than 10 mg/kg). Twelve hours after administration, plasma levels of this metabolite in several patients treated with low doses exceeded those of methotrexate. No 7-hydroxymethotrexate was found in CSF after CNS administration of methotrexate; however, small amounts of the metabolite was found in the CSF after intravenous high dose infusion. We conclude that methotrexate is significantly metabolized in man at all doses used clinically.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7403667

Source DB:  PubMed          Journal:  Res Commun Chem Pathol Pharmacol        ISSN: 0034-5164


  7 in total

Review 1.  Clinical pharmacokinetics of methotrexate in children.

Authors:  Y M Wang; T Fujimoto
Journal:  Clin Pharmacokinet       Date:  1984 Jul-Aug       Impact factor: 6.447

2.  Pharmacokinetics of methotrexate and 7-hydroxy-methotrexate in plasma and bone marrow of children receiving low-dose oral methotrexate.

Authors:  P Sonneveld; F W Schultz; K Nooter; K Hählen
Journal:  Cancer Chemother Pharmacol       Date:  1986       Impact factor: 3.333

Review 3.  Pharmacokinetics of anticancer drugs in children.

Authors:  W R Crom; A M Glynn-Barnhart; J H Rodman; M E Teresi; R E Kavanagh; M L Christensen; M V Relling; W E Evans
Journal:  Clin Pharmacokinet       Date:  1987-03       Impact factor: 6.447

4.  Pharmacokinetics of methotrexate and 7-hydroxy-methotrexate in rabbits after intravenous administration.

Authors:  M L Chen; W L Chiou
Journal:  J Pharmacokinet Biopharm       Date:  1983-10

5.  Plasma levels of 7-hydroxymethotrexate after high-dose methotrexate treatment.

Authors:  G Milano; A Thyss; N Renee; M Schneider; M Namer; J L Boublil; C M Lalanne
Journal:  Cancer Chemother Pharmacol       Date:  1983       Impact factor: 3.333

6.  Kinetics of 7-hydroxy-methotrexate after high-dose methotrexate therapy.

Authors:  R Erttmann; S Bielack; G Landbeck
Journal:  Cancer Chemother Pharmacol       Date:  1985       Impact factor: 3.333

7.  High-dose 7-hydromethotrexate: acute toxicity and lethality in a rat model.

Authors:  E Smeland; O M Fuskevåg; K Nymann; J S Svendesn; R Olsen; S Lindal; R M Bremnes; J Aarbakke
Journal:  Cancer Chemother Pharmacol       Date:  1996       Impact factor: 3.333

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.